Biomaterials Market

Biomaterials Market Size (2022 to 2027)

The global biomaterials market is estimated to be worth 126.63 billion USD in 2023 and 249.22 billion by 2028, growing at a CAGR of 14.5% during the forecast period. Over the past few years, the demand for biomaterials usage in different medical applications has increased globally.

Biomaterials Market Share Insights:

• Based on application, the orthopedic segment covered the largest share of 23.4% in 2022.
• Based on biomaterial type, the Metallic Biomaterials segment dominated in 2022 and is expected to lead as usual during the forecast period.
• The North American biomaterials market got the largest share in 2021 and is expected to be worth USD 72.09 billion by 2027
• Asia Pacific biomaterials market showcased the fastest CAGR of  16.58% during the forecast period.

A biomaterial is any substance or combination of synthetic or natural origin. Biomaterials are vital in orthopedic surgeries, most notably in knee replacements. According to the Journal of Bone and Joint Surgery, knee replacement demand will rise enormously in the coming years. A similar source proposes the need for entire hip replacements to register 572,000 patients by 2030. With such an incredible increase in demand in the orthopedic sector, the biomaterials market will soon be subject to significant growth. Nanotechnology contributions researchers are working on recovering energy from the human body to use power to operate implantable biomedical devices.

MARKET DRIVERS:

The growing aging population and rising prevalence of chronic diseases worldwide drive the global biomaterials market growth.

The usage of biomaterials in various procedures has increased significantly in recent years that include orthopedic implants, cardiovascular stents, dental implants and tissue engineering. The number of people aging worldwide is on the rise. As per the statistics published by World Health Organization (WHO), the number of people with age 60 years or above is expected to reach 2.1 billion worldwide. People are more likely to suffer from various diseases and require medical interventions such as joint replacements, cardiovascular procedures, and dental implants. Biomaterials are the finest materials used in the manufacturing of implants and devices and are compatible with the human body. Medical devices and medical implants that are manufactured with biomaterials promote successful integration and offer a reduced risk of complications. On the other hand, the number of people suffering from chronic diseases is growing rapidly worldwide. The growing prevalence of chronic diseases is driving the demand for the materials and components that are required for the manufacturing of required medical devices including biomaterials. This trend is likely to continue in the coming years and drive the market growth.

The growing demand for regenerative medicine further fuels the growth rate of the biomaterials market. Biomaterials are being used in the development of regenerative medicine.

The adoption of regenerative medicine has increased tremendously in recent years due to its ability to repair or replace damaged tissues and organs. The usage of regenerative medicine is expected to grow in the coming years due to the increasing prevalence of chronic diseases and rising demand for effective treatments driving the demand for biomaterials and boosting market growth.

The rising number of advancements in biomaterials science and technology, increasing awareness of biocompatibility, growing funding, and an increasing number of initiatives from the governments of various countries to support the R&D in the field of biomaterials, rising emphasis on personalized medicine and growing emphasis on developing sustainable and eco-friendly materials across industries boost the market’s growth rate. The compatibility of biomaterials with 3D printing and the growing number of R&D activities by academic institutions, research organizations, and companies to explore the potential benefits of biomaterials in various applications further propel the biomaterials market growth.

MARKET RESTRAINTS:

Factors like the high cost of biomaterial production and polymers, inflammatory responses found because of compatibility issues, and complications with these products limit the growth rate of the global biomaterials market. Lack of knowledge of biomaterial devices is slowly hampering demand for the market. The equipment in the laboratories requires massive amounts for maintenance and installation; strict rules and regulations taken by the government in concern for patients' health are limiting the market's growth.

Impact of COVID-19 on the global biomaterials market:

The World Health Organization declared a pandemic on March 11, 2020, in response to the recent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks (COVID-19). Biomaterials are synthetic or natural materials that are artificially derived and used in medical technology to enhance damaged tissues and organs. Biomaterials interacting with biological processes are used in medical applications such as respiratory, dental, orthopedic, and neurological disorders. Moreover, heavy funding by government agencies for the invention of new goods provides new scope for the growth of the biomaterials market. With the World Health Organization (WHO) declaring the COVID-19 epidemic a pandemic, several established pharmaceutical and biopharmaceutical firms and small start-ups have moved forward to produce therapies and vaccines to combat the novel coronavirus infection. However, the pandemic and nationwide lockdowns have resulted in revenues declining because most countries are major biomaterials suppliers. As a result, the demand for the biomaterials market suffered a minor downturn during this pandemic.

REPORT COVERAGE:

This research report has segmented and sub-segmented the global biomaterials market into categories based on biomaterial type, application, and region.

Biomaterials Market - By Biomaterial Type:

• Ceramic Biomaterials
• Metallic Biomaterials
• Polymer Biomaterials
• Natural Biomaterials

Based on biomaterial type, the metallic biomaterials segment accounted for the largest share of the global biomaterials market in 2022 and the segmental domination is expected to continue throughout the forecast period. The rising use of metals in manufacturing cardiovascular, dental and orthopedic medical devices is one of the key factors propelling the segmental growth. Since biomaterials are made up of artificial or natural materials, metals are also used to manufacture implants, fabricate structures, or replace lost or diseased biological structures and this help in improving the quality of life and longevity of human beings since metals have the excellent property of thermal conductivity and other mechanical properties, which makes them find application in many fields, such as in stents in blood vessels, artificial valves in the heart, replacement implants in elbows, hips, ears, shoulders, knees, and orthodontal structures. Thus, to meet the demands of the rapidly aging population, this segment is expected to grow at a high rate over the forecast period.

However, the segment of polymeric biomaterials is expected to grow at the fastest CAGR during the forecast period due to the increasing use of polymers in soft tissue applications such as plastic surgery. The growing use of polymers in healthcare and soft tissue, such as plastic surgeries drive the segmental growth. For many years, researchers have developed many new strategies for the exploration of Natural and synthetic polymers to successfully design advanced polymer biomaterials to be applied in the field of tissue engineering and regeneration, a fast-growing industry at a high pace in recent years. Therefore, recent technological advancements have advanced self-healing and shape-memory properties in preparing innovative polymeric biomaterials. This has helped the manufacturers approach new methods of developing hydrogels, films, and 3D printable biomaterials using different polymeric biomaterials. In addition, its properties like flexibility, longevity, biocompatibility, bioinertness, and durability have increased ophthalmological disorders. Based on usage, both biodegradable and bio-stable polymers are used in healthcare. Thus, these factors are hoping to drive the market over the forecast period under this segment.

Biomaterials Market - By Application:

• Orthopedic
• Dental
• Cardiovascular
• Plastic surgery
• Wound healing
• Ophthalmology
• Tissue engineering
• Neurological
• Others

Based on application, the orthopedic segment accounted for the major share of the global biomaterials market worldwide in 2022 and is expected to grow at a healthy CAGR during the forecast period.

The dental segment is predicted to grow at a promising CAGR during the forecast period owing to the rising concern for healthcare and the growing urban population. The rising awareness of next-generation sequencing techniques and increasing usage of biomaterials in various applications further contribute to the segmental growth

The neurological segment is also anticipated to hold a considerable share of the global market during the forecast period. The growing number of people suffering from neurological disorders primarily boost the segmental growth. Thus, there has been a growing need for effective treatment methods for these diseases, resulting in market players and manufacturers shifting focus on biomaterials with the efforts underway to produce an ideal scaffold. They aim to improve the limitations of purely cellular therapies, produce biomaterials that exactly match the biological and mechanical properties of the tissue, and also study the philosophy of neural tissue engineering, which has emerged recently.

Biomaterials Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, the North American biomaterials market captured the major share of the global market in 2022 and the domination of the North American region is expected to continue throughout the forecast period. The presence of well-established healthcare infrastructure, high adoption rate of advanced medical technologies, extensive government support and funding for research and development in biomaterials, growing prevalence of chronic diseases and increasing aging population primarily propel the North American market growth. The presence of key biomaterial manufacturers and market players further contribute to the growth rate of the North American market. The U.S. had the major share of the North American market in 2022 and is estimated to progress at a healthy CAGR during the forecast period owing to the rising demand for regenerative medicine and personalized healthcare solutions and increasing emphasis on sustainable and eco-friendly biomaterials.

Europe's biomaterials market is a notable regional market for biomaterials worldwide and is predicted to grow substantially during the forecast period. The presence of robust regulatory framework supporting the development and commercialization of biomaterials, strong presence of academic institutions and research centers driving innovation in biomaterials, growing geriatric population, high healthcare expenditure and rising demand for bioactive and biodegradable materials in medical applications primarily drive the European market growth. The UK followed by Germany led the market in Europe due to the rising Emphasis on precision medicine and personalized healthcare solutions, favourable reimbursement policies for biomaterial-based medical devices and implants.

The APAC biomaterials market is predicted to witness the fastest CAGR in the global market during the forecast period. The rapidly improving healthcare infrastructure, increasing healthcare expenditure, growing prevalence of chronic diseases, increasing middle-class population, rising medical tourism industry, growing adoption of patients seeking advanced biomaterial-based treatments and increasing focus on research and development, particularly in countries like Japan and South Korea promote the APAC market growth. The growing of 3D printing technology for customized biomaterial implants and increasing government initiatives to promote domestic production and innovation in biomaterials further contribute to the APAC market growth.

Latin America's biomaterials market is estimated to hold a considerable share of the global market during the forecast period. The growing healthcare spending, improving healthcare infrastructure, rising medical device industry and rising demand for biomaterial-based implants, growing prevalence of chronic diseases, such as cardiovascular disorders and diabetes and expansion of private healthcare sector and medical tourism propel the Latin American market growth. The growing awareness and adoption of regenerative medicine and tissue engineering and increasing number of initiatives from the governments of Latin American countries to enhance research capabilities and attract investments in biomaterials boost the Latin American market growth.

MEA biomaterials market held a moderate share of the global market in 2022 and is predicted to grow steadily during the forecast period owing to the rising demand for biomaterial-based orthopedic and dental implants and increasing number of initiatives from the governments of MEA countries to develop domestic manufacturing capabilities in biomaterials.

KEY MARKET PARTICIPANTS:

Some of the noteworthy players in the global biomaterials market covered in this report are Carpenter Technology Corporation (United States), Evonik Industries (Germany), Berkeley Advanced Biomaterials (United States), Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (United States), CoorsTek Inc. (United States), CeramTec (Germany), and GELITA AG (Germany).

RECENT MARKET DEVELOPMENTS:

• In Dec 2022, Celularity Inc., a biotechnology company creating biomaterials products along with allogeneic placenta-derived cell therapies, received a Halal certification after going through rigorous evaluation to check the permissibility under Islamic law. The certificate had been granted for all of its commercial-stage biomaterials products, commercial models, and clinical-stage cell therapy programs widely used for clinical and experimental procedures. This certification issued under the authority of Circle H International, Inc. would enable the Company to serve Islamic markets globally, with a priority focus on Saudi Arabia and the Middle East and North Africa regions, leading to Celularity's global expansion strategy.
• In Dec 2022, Rest Duvet partnered with Noble Biomaterials to introduce its new innovative product, Silvercool Performance. The pillowcases and sheets or Silvercool have helped the Company to restore sleep through constant innovation in materials and technology through the built-in high thermal conductivity fabric. Along with this, the patented combination of the two features of an antimicrobial technology that kills odor and stain-causing bacteria makes the Silvercool a unique and technologically advanced type of bedding. With the advantages of making one of the most excellent and highest Qmax fabrics due to the mechanism of absorbing and transferring heat faster than bamboo, cotton, and silk, Silvercool aims to make a new meaning to a dream come true.
• In November 2022, a framework collaboration agreement was signed by a division of South Korea's CJ CheilJedang and NatureWorks to develop C.J. Biomaterials' Phact biodegradable polymers and NatureWorks' Ingeo biopolymers. The leading producer of proprietary PHA (poly hydroxy alkanoate) and the world's largest producer of PLA (polylactic acid) aim to make a sustainable material solution for applications ranging from catering utensils, compostable food packaging to personal care, films, and other end products.